PUM1
OFFICE ACTION ISSUED POU1
05/20/2026
Back to search
Official data from USPTO
TURN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TURN THERAPEUTICS
ST13
US500000088044977Class
5, 42
Filing
88044977
Registration
6283602
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
05/21/2026
Trademark type
Word
Nice classes
5, 42
Filing date
07/19/2018
Registration date
03/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/02/2021
Last transaction
05/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/31/2019
First use in commerce
07/31/2019
Drawing code
4
Owner type
03
Owner location
Calabasas, CA, US
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GLOBAL HEALTH SOLUTIONS, INC.
Global Health Solutions LLC
Global Health Solutions LLC
Representatives
Turn Therapeutics Inc.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment and prevention of infectious diseases; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists; Pharmaceutical preparationsantivirals; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposesfor infectious diseases; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ocular pharmaceuticals; Plant extracts for pharmaceutical purposes
Class 42
Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
40 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/20/2026
ES8R
TEAS SECTION 8 RECEIVED
04/24/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/02/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/28/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/27/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/27/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/25/2021
IUAF
USE AMENDMENT FILED
01/06/2021
EISU
TEAS STATEMENT OF USE RECEIVED
01/06/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/10/2020
EX3G
SOU EXTENSION 3 GRANTED
07/08/2020
EXT3
SOU EXTENSION 3 FILED
07/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/04/2020
EX2G
SOU EXTENSION 2 GRANTED
01/02/2020
EXT2
SOU EXTENSION 2 FILED
01/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/09/2019
EX1G
SOU EXTENSION 1 GRANTED
07/05/2019
EXT1
SOU EXTENSION 1 FILED
07/05/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/29/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/29/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2018
ALIE
ASSIGNED TO LIE
10/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/22/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
09/22/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/22/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
09/22/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/22/2018
DOCK
ASSIGNED TO EXAMINER
09/21/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/24/2018
NWAP
NEW APPLICATION ENTERED
07/23/2018
Continuous trademark protection
Get notified about every new filing that threatens TURN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.